Connect with us
Technological advances in genomics, AI, and immunology are transforming breast cancer research, enabling personalized treatments and improved understanding of tumor biology. Key focuses include hereditary genetics,...
The Clara Campal Comprehensive Oncology Centre (HM Ciocc) leads cancer research in Madrid's private sector, with 144 trials recruiting and 374 active studies in 2024. Focused...
AseBio and Aelmhu praised the first Joint Committee meeting on Spain’s 2024-2028 Pharmaceutical Industry Strategy, emphasizing collaboration between ministries and industry. AseBio supports fostering biotechnology growth,...
Grifols secured a $21 million grant from the Michael J. Fox Foundation to study plasma biomarkers for early Parkinson’s detection. The 10-year Chronos PD project will...
The biotech industry thrived during the pandemic, fueled by vaccine demand, but post-2022 saw capital declines. In 2024, capital increases reached €999 million, led by Qiagen...
German biotech financing surged 78% in 2024, totalling €1.92 billion, driven by venture capital (€898 million), public market funding (€999 million), and an IPO. Notable deals...
Global markets saw mixed performances: DAX fell 0.6% to 19,909 points, pressured by BASF, BMW, and Bayer. MDAX and TecDAX also dropped. Hang Seng gained 0.7%,...
In 2024, Spanish pharma focused on stabilizing finances rather than expanding, with six major players seeing an 18% profit drop compared to 2023. While Faes Farma...
Zerintia HealthTech, a Spanish digital health firm, expands into Saudi Arabia and the UAE with its 4RemoteHealth platform, enabling real-time remote collaboration in complex medical settings....
Grifols faced a turbulent 2024 with leadership changes, legal battles, and debt refinancing. Accusations by Gotham City Research and a rejected takeover bid from Brookfield added...
 |
|
 |  |
 |
|